Accrol Group launches second ESG report 

Accrol Group Holdings plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Accrol Group Holdings plc (LON:ACRL), the UK’s leading independent tissue converter, has announced that it has today published its latest Environmental, Social and Governance Report, which is available on the Group’s website: https://www.accrol.co.uk/esg/  

Key report highlights

Environmental performance:

·    15% reduction in tissue waste

·    3% reduction in energy use

·    8% reduction in carbon emissions and still a business in growth

·    15% more rolls per journey achieved removing c.12% trucks off the road

Social performance:

·    Living Wage accredited employer – the only accredited UK tissue manufacturer

·    Zero lost-time accidents

·    Engaged workforce with 89% colleagues proud to work for Accrol

·    22% of females in leadership roles (+6% vs 2020)

Governance performance:

·    All sites A or AA BRCGS accredited providing trusted reassurance to leading retailers

·    Compliant Sedex member supporting responsible and sustainable business and supply chain decisions

·    Supplier code of conduct launched

Gareth Jenkins, Chief Executive Officer of Accrol Group, said:

“Since the launch of our maiden ESG report a year ago, Accrol’s ESG agenda has become even more integral to how we do business. Our approach to ESG makes clear the KPIs and measures we’ve set ourselves, so our stakeholders understand how our ESG framework shapes performance and the standards set.

It enables us to stay focused on long-term sustainable commercial success not just short-term return. It’s great to share some of these examples with you in this year’s report.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Accrol Group Holdings plc (LON:ACRL) has announced the publication of a shareholder circular detailing terms of the Scheme. Learn more here.
Discover the latest results and overview of Accrol Group Holdings, the UK's top independent tissue converter, led by CEO Gareth Jenkins and CFO Chris Welsh.
In this interview, Gervais Williams, co-fund manager of Miton UK MicroCap Trust, discusses navigating the economic landscape and standout companies in 2024. Find out more here. #investment #microcap
Accrol Group Holdings plc has reported strong H1 FY24 results, with impressive growth in adjusted EBITDA and adjusted PBT. The company remains on track to meet expectations and has seen gains in market share. Furthermore, the private label segment of the UK tissue market continues to increase, and the sales of biodegradable wet wipes have been exceptionally strong. Accrol's outlook remains positive with expected further volume growth.
Accrol Group Holdings plc has reported strong performance in H1 FY24, with branded volumes rising by 45% and margins returning to pre-pandemic levels. The group is on track to deliver FY24 results in line with expectations and expects to outperform previous expectations for FY25.

Search

Search